Injective Rallies 8% as Trading Volume Climbs

Injective ($INJ) rallied more than 8% on October 16, reaching $9.35 as increased trading activity and renewed interest in the network's institutional developments supported its recovery, according to CryptoNews. The token recovered from an intraday low of $8.50, pushing above its trading range seen earlier in the month.

Institutional Developments and Partnerships

Market sentiment has been supported by institutional developments, including Gulf Labs—a subsidiary of Thailand's GULF Group—joining Injective as an institutional validator on its blockchain. The partnership covers potential work involving tokenization, stablecoins, institutional financial services, and digital infrastructure in Thailand. Additionally, Canary Capital filed an amended S-1 registration statement with the SEC in December 2025 for a proposed staked Injective exchange-traded fund to trade on the Cboe BZX Exchange.

Technical Indicators

Technical indicators on the daily INJ/USDT chart showed buyers retaining control as the token traded near $9.25, according to TradingView data from Binance. Daily Ichimoku Cloud and DMI readings remained bullish, while rising four-hour On-Balance Volume showed stronger buying participation during the rally. However, the four-hour Commodity Channel Index climbed above 200, suggesting the asset could face consolidation following the positive momentum.

Key facts

• Injective rallied over 8% on October 16, reaching $9.35 and recovering from an intraday low of $8.50.
• Gulf Labs joined Injective as an institutional validator to participate in transaction validation, network security, and governance.
• Canary Capital previously filed an amended S-1 registration statement with the SEC for a proposed staked Injective exchange-traded fund.
• Daily Ichimoku Cloud and Directional Movement Index readings remained bullish, while the four-hour CCI climbed above 200.